0001493152-22-003846.txt : 20220211
0001493152-22-003846.hdr.sgml : 20220211
20220210182027
ACCESSION NUMBER: 0001493152-22-003846
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20220211
DATE AS OF CHANGE: 20220210
EFFECTIVENESS DATE: 20220211
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Advaxis, Inc.
CENTRAL INDEX KEY: 0001100397
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841521955
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1031
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-433189
FILM NUMBER: 22615779
BUSINESS ADDRESS:
STREET 1: 9 DEER PARK DRIVE
STREET 2: SUITE K-1
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
BUSINESS PHONE: 732 545 1590
MAIL ADDRESS:
STREET 1: 9 DEER PARK DRIVE
STREET 2: SUITE K-1
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
FORMER COMPANY:
FORMER CONFORMED NAME: GREAT EXPECTATIONS & ASSOCIATES INC
DATE OF NAME CHANGE: 19991203
D
1
primary_doc.xml
X0708
D
LIVE
0001100397
Advaxis, Inc.
9 DEER PARK DRIVE, SUITE K-1
MONMOUTH JUNCTION
NJ
NEW JERSEY
08852
732-545-1590
DELAWARE
None
GREAT EXPECTATIONS & ASSOCIATES INC
Corporation
true
Kenneth
Berlin
9 Deer Park Drive, Suite K-1
Monmouth Junction
NJ
NEW JERSEY
08852
Executive Officer
Director
David
Sidransky
c/o Advaxis, Inc.
9 Deer Park Drive, Suite K-1
Monmouth Junction
NJ
NEW JERSEY
08852
Director
James
Patton
c/o Advaxis, Inc.
9 Deer Park Drive, Suite K-1
Monmouth Junction
NJ
NEW JERSEY
08852
Director
Roni
Appel
c/o Advaxis, Inc.
9 Deer Park Drive, Suite K-1
Monmouth Junction
NJ
NEW JERSEY
08852
Director
Richard
Berman
c/o Advaxis, Inc.
9 Deer Park Drive, Suite K-1
Monmouth Junction
NJ
NEW JERSEY
08852
Director
Samir
Khleif
c/o Advaxis, Inc.
9 Deer Park Drive, Suite K-1
Monmouth Junction
NJ
NEW JERSEY
08852
Director
Igor
Gitelman
c/o Advaxis, Inc.
9 Deer Park Drive, Suite K-1
Monmouth Junction
NJ
NEW JERSEY
08852
Executive Officer
Andres
Gutierrez
c/o Advaxis, Inc.
9 Deer Park Drive, Suite K-1
Monmouth Junction
NJ
NEW JERSEY
08852
Executive Officer
Biotechnology
$1,000,001 - $5,000,000
- 06b
false
2022-01-31
false
true
false
380000
A.G.P./Alliance Global Partners
8361
None
None
590 MADISON AVENUE, 28TH FLOOR
NEW YORK
NY
NEW YORK
10022
IL
ILLINOIS
NY
NEW YORK
false
4750000
4750000
0
This amount reflects a private placement of 1,000,000 shares of the Company's Series D Convertible Redeemable Preferred Stock, par value $0.001, which will be convertible, at a conversion price of $0.25 per share (subject to adjustments).
false
6
0
295000
In connection with the transaction, A.G.P./Alliance Global Partners received placement agent fees in the aggregate amount of $295,000.
0
The proceeds from the offering will not be used for payments to any of the persons identified as related persons in response to Item 3.
false
Advaxis, Inc.
/s/ Kenneth A. Berlin
Kenneth A. Berlin
President, Chief Executive Officer and Interim CFO
2022-02-10